Trials / Completed
CompletedNCT01205893
Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA
Study to Confirm the Safety and Efficacy of the Reducer on Patients With Refractory Angina
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Shockwave Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if the Reducer is safe and effective in treating the symptoms of refractory angina in patients that suffer from refractory angina who demonstrate reversible ischemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neovasc Reducer | Implantation of the Reducer |
| DEVICE | Control | Control - No device implanted |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2013-10-01
- Completion
- 2013-11-01
- First posted
- 2010-09-21
- Last updated
- 2013-11-25
Locations
11 sites across 6 countries: Belgium, Canada, Denmark, Netherlands, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT01205893. Inclusion in this directory is not an endorsement.